News
Ultragenyx Pharmaceutical Inc and Takeda Pharmaceutical Company enter into a Collaboration to Develop Rare Genetic Diseases
Ultragenyx Pharmaceutical Inc. a biopharmaceutical company focused on the development of novel productsfor rare and ultra-rare genetic diseases, and Takeda Pharmaceutical Company Limited announced...
Press Releases
ALF 5000: New Filling and Closing Machine for Ampoules and Injection Bottles from Bosch
Increased performance and higher safety Output of up to 600 containers per minute Flexible use: compatible with all commonfilling systems...
Research Insight
Boehringer Ingelheim and Harvard scientists establish a research alliance
Boehringer Ingelheim announced it has established a research collaboration with the Harvard Stem Cell Institute’s - Harvard Fibrosis Network to discover new ways of...
News
Novartis data show more than 50 percent of eligible Ph+ CML patients maintain Treatment-free Remission after stopping Tasigna
In ENESTfreedom, 51.6% of eligible first-line Tasigna patients maintained TFR for 48 weeks after stopping treatment; study did not meet its statistical primary...
Press Releases
AstraZeneca,Ironwood enter U.S. licensing agreement for lesinurad
AstraZeneca announced that it has completed the licensing agreement with Ironwood Pharmaceuticals for the exclusive US rights to Zurampic (lesinurad) and the fixed-dose combination...
Press Releases
Shire Plc completes combination with Baxalta Inc creating global biotech leader in rare diseases
Shire plc completed its previously announced combination with Baxalta Incorporated ,creating the leading global biotechnology company focused on serving patients with rare diseases and...
Press Releases
Mylan NV launches generic version of Celgenes Vidaza injection
Mylan N.V. announced the U.S. launch of Azacitidine for Injection, 100 mg/vial, which is a generic version of Celgene's Vidaza® Injection, 100 mg/vial. Mylan...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read